Search by Drug Name or NDC
NDC 70000-0415-02 leader clearlax 17 g/17g Details
leader clearlax 17 g/17g
leader clearlax is a ORAL POWDER, FOR SOLUTION in the HUMAN OTC DRUG category. It is labeled and distributed by Cardinal Health 110, LLC. dba Leader. The primary component is POLYETHYLENE GLYCOL 3350.
MedlinePlus Drug Summary
Polyethylene glycol 3350 is used to treat occasional constipation. Polyethylene glycol 3350 is in a class of medications called osmotic laxatives. It works by causing water to be retained with the stool. This increases the number of bowel movements and softens the stool so it is easier to pass.
Related Packages: 70000-0415-02Last Updated: 12/01/2022
MedLinePlus Full Drug Details: Polyethylene Glycol 3350
Product Information
NDC | 70000-0415 |
---|---|
Product ID | 70000-0415_abf92abe-b5f3-4925-823f-5b28d0b15253 |
Associated GPIs | 46600033002910 |
GCN Sequence Number | 041843 |
GCN Sequence Number Description | polyethylene glycol 3350 POWDER 17 G/DOSE ORAL |
HIC3 | D6S |
HIC3 Description | LAXATIVES AND CATHARTICS |
GCN | 86212 |
HICL Sequence Number | 022819 |
HICL Sequence Number Description | POLYETHYLENE GLYCOL 3350 |
Brand/Generic | Generic |
Proprietary Name | leader clearlax |
Proprietary Name Suffix | n/a |
Non-Proprietary Name | Polyethylene Glycol 3350 |
Product Type | HUMAN OTC DRUG |
Dosage Form | POWDER, FOR SOLUTION |
Route | ORAL |
Active Ingredient Strength | 17 |
Active Ingredient Units | g/17g |
Substance Name | POLYETHYLENE GLYCOL 3350 |
Labeler Name | Cardinal Health 110, LLC. dba Leader |
Pharmaceutical Class | Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE] |
DEA Schedule | n/a |
Marketing Category | ANDA |
Application Number | ANDA090685 |
Listing Certified Through | 2024-12-31 |
Package
Package Images

NDC 70000-0415-02 (70000041502)
NDC Package Code | 70000-0415-2 |
---|---|
Billing NDC | 70000041502 |
Package | 238 g in 1 BOTTLE (70000-0415-2) |
Marketing Start Date | 2019-02-19 |
NDC Exclude Flag | N |
Pricing Information | |
Price Per Unit | 0.02425 |
Pricing Unit | GM |
Effective Date | 2024-02-21 |
NDC Description | CLEARLAX POWDER |
Pharmacy Type Indicator | C/I |
OTC | Y |
Explanation Code | 1, 5 |
Classification for Rate Setting | G |
As of Date | 2024-02-21 |
This pricing file, entitled the NADAC (National Average Drug Acquisition
Cost) files, provide
state Medicaid agencies with covered outpatient drug prices by averaging
survey invoice
prices from retail community pharmacies across the United States. These
pharmacies include
independent retail community pharmacies and chain pharmacies. The prices
are updated on a
weekly and monthly basis
Standard Product Labeling (SPL)/Prescribing Information SPL 812c59b0-e7ce-4c7a-91ed-e74b7b1b84be Details
Use
Warnings
Allergy alert: Do not use if you are allergic to polyethylene glycol
Ask a doctor before use if you have
- •
- nausea, vomiting or abdominal pain
- •
- a sudden change in bowel habits that lasts over 2 weeks
- •
- irritable bowel syndrome
Directions
- •
- do not take more than directed unless advised by your doctor
- •
- the bottle top is a measuring cap marked to contain 17 grams of powder when filled to the indicated line (white section in cap)
- •
- adults and children 17 years of age and older:
- •
- fill to top of white section in cap which is marked to indicate the correct dose (17 g)
- •
- stir and dissolve in any 4 to 8 ounces of beverage (cold, hot or room temperature) then drink
- •
- ensure that the powder is fully dissolved before drinking
- •
- do not drink if there any clumps
- •
- use once a day
- •
- use no more than 7 days
- •
- children 16 years of age or under: ask a doctor
Other information
Principal Display Panel
INGREDIENTS AND APPEARANCE
LEADER CLEARLAX
polyethylene glycol 3350 powder, for solution |
|||||||||||||||||||||||||
|
|||||||||||||||||||||||||
|
|||||||||||||||||||||||||
|
|||||||||||||||||||||||||
|
|||||||||||||||||||||||||
|
Labeler - Cardinal Health 110, LLC. dba Leader (063997360) |
Revised: 4/2021
Document Id: abf92abe-b5f3-4925-823f-5b28d0b15253
Set id: 812c59b0-e7ce-4c7a-91ed-e74b7b1b84be
Version: 5
Effective Time: 20210421